These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9122262)

  • 21. Modification of gamma-aminobutyric acidA receptor binding and function by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vitro and in vivo: effects of aging.
    Miller LG; Lumpkin M; Galpern WR; Greenblatt DJ; Shader RI
    J Neurochem; 1991 Apr; 56(4):1241-7. PubMed ID: 1848276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
    Oz M; Zhang L; Rotondo A; Sun H; Morales M
    Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional variability in changes in 5-HT2A receptor mRNA levels in rat brain following irreversible inactivation with EEDQ.
    Raghupathi RK; Artymyshyn R; McGonigle P
    Brain Res Mol Brain Res; 1996 Jul; 39(1-2):198-206. PubMed ID: 8804728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols.
    Cussac D; Newman-Tancredi A; Quentric Y; Carpentier N; Poissonnet G; Parmentier JG; Goldstein S; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):242-52. PubMed ID: 11882920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of the alkylating agent N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on brain alpha 2-adrenoceptors and I2-imidazoline sites in vitro and in vivo.
    Miralles A; Ribas C; Olmos G; García-Sevilla JA
    J Neurochem; 1993 Nov; 61(5):1602-10. PubMed ID: 8228980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-related assessment of central 5-HT1A receptors following irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Keck J; Lakoski JM
    Brain Res; 1996 Jul; 728(1):130-4. PubMed ID: 8864308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat.
    Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
    Neuropharmacology; 1994 May; 33(5):647-55. PubMed ID: 7936100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Irreversible modification of the voltage-sensitive calcium channel by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Gopalakrishnan M; Triggle DJ
    Biochem Pharmacol; 1990 Jul; 40(2):327-32. PubMed ID: 1973894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between alpha 2-adrenergic receptor binding sites and the functional receptors inhibiting norepinephrine release in rat cerebral cortex.
    Nasseri A; Minneman KP
    Mol Pharmacol; 1987 Nov; 32(5):655-62. PubMed ID: 2891027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of the peptide-coupling agent, EEDQ, on 5-HT2A receptor binding and function in rat frontal cortex.
    Kettle CJ; Cheetham SC; Martin KF; Prow MR; Heal DJ
    Neuropharmacology; 1999 Sep; 38(9):1421-30. PubMed ID: 10471096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro.
    Hess EJ; Battaglia G; Norman AB; Creese I
    Mol Pharmacol; 1987 Jan; 31(1):50-7. PubMed ID: 3100940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of sensory neuron excitability by serotonin involves 5HT2C receptors and Ca(2+)-activated chloride channels.
    Salzer I; Gantumur E; Yousuf A; Boehm S
    Neuropharmacology; 2016 Nov; 110(Pt A):277-286. PubMed ID: 27511837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional reconstitution in situ of 5-hydroxytryptamine2c (5HT2c) receptors with alphaq and inverse agonism of 5HT2c receptor antagonists.
    Hartman JL; Northup JK
    J Biol Chem; 1996 Sep; 271(37):22591-7. PubMed ID: 8798428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anatomical localization of SKF-38393-induced behaviors in rats using the irreversible monoamine receptor antagonist EEDQ.
    Neisewander JL; Ong A; McGonigle P
    Synapse; 1995 Feb; 19(2):134-43. PubMed ID: 7725242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-dependent differences in the rate of recovery of striatal dopamine D1 and D2 receptors after inactivation with EEDQ.
    Crawford CA; Rowlett JK; McDougall SA; Bardo MT
    Eur J Pharmacol; 1994 Feb; 252(2):225-31. PubMed ID: 8157063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alkylation of [3H]8-OH-DPAT binding sites in rat cerebral cortex and hippocampus.
    Nénonéné EK; Radja F; Carli M; van Gelder NM; Afkhami-Dastjerdian S; Reader TA
    Neurochem Res; 1996 Feb; 21(2):167-76. PubMed ID: 9182242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the alkylating agent EEDQ on regulatory G proteins and recovery of agonist and antagonist alpha2-adrenoceptor binding sites in rat brain.
    Ribas C; Miralles A; Escribá PV; García-Sevilla JA
    Eur J Pharmacol; 1998 Jun; 351(1):145-54. PubMed ID: 9698216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meiosis reinitiation in surf clam oocytes is mediated via a 5-hydroxytryptamine5 serotonin membrane receptor and a vitelline envelope-associated high affinity binding site.
    Krantic S; Guerrier P; Dubé F
    J Biol Chem; 1993 Apr; 268(11):7983-9. PubMed ID: 8385130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.